BACKGROUND: Obesity is associated with clinical depression among women. However, depressed women are often excluded from weight loss trials. PURPOSE: This study examined treatment outcomes among women with comorbid obesity and depression. METHODS:Two hundred three (203) women were randomized to behavioral weight loss (n = 102) or behavioral weight loss combined with cognitive-behavioral depression management (n = 101). RESULTS:Average participant age was 52 years; mean baseline body mass index was 39 kg/m(2). Mean Patient Health Questionnaire and Hopkins Symptom Checklist (SCL-20) scores indicated moderate to severe baseline depression. Weight loss and SCL-20 changes did not differ between groups at 6 or 12 months in intent-to-treat analyses (p = 0.26 and 0.55 for weight, p = 0.70 and 0.25 for depressive symptoms). CONCLUSIONS: Depressed obese women lost weight and demonstrated improved mood in both treatment programs. Future weight loss trials are encouraged to enroll depressed women.
RCT Entities:
BACKGROUND:Obesity is associated with clinical depression among women. However, depressedwomen are often excluded from weight loss trials. PURPOSE: This study examined treatment outcomes among women with comorbid obesity and depression. METHODS: Two hundred three (203) women were randomized to behavioral weight loss (n = 102) or behavioral weight loss combined with cognitive-behavioral depression management (n = 101). RESULTS: Average participant age was 52 years; mean baseline body mass index was 39 kg/m(2). Mean Patient Health Questionnaire and Hopkins Symptom Checklist (SCL-20) scores indicated moderate to severe baseline depression. Weight loss and SCL-20 changes did not differ between groups at 6 or 12 months in intent-to-treat analyses (p = 0.26 and 0.55 for weight, p = 0.70 and 0.25 for depressive symptoms). CONCLUSIONS:Depressed obesewomen lost weight and demonstrated improved mood in both treatment programs. Future weight loss trials are encouraged to enroll depressedwomen.
Authors: Evette Ludman; Gregory E Simon; Laura E Ichikawa; Belinda H Operskalski; David Arterburn; Jennifer A Linde; Robert W Jeffery; Paul Rohde; Emily A Finch Journal: Behav Med Date: 2010 Impact factor: 3.104
Authors: Kristin L Schneider; Jamie S Bodenlos; Yunsheng Ma; Barbara Olendzki; Jessica Oleski; Philip Merriam; Sybil Crawford; Ira S Ockene; Sherry L Pagoto Journal: BMC Psychiatry Date: 2008-09-15 Impact factor: 3.630
Authors: Jun Ma; Lisa Goldman Rosas; Nan Lv; Lan Xiao; Mark B Snowden; Elizabeth M Venditti; Megan A Lewis; Jeremy D Goldhaber-Fiebert; Philip W Lavori Journal: JAMA Date: 2019-03-05 Impact factor: 56.272
Authors: John A Naslund; Kelly A Aschbrenner; Sarah I Pratt; Matthew C Lohman; Emily A Scherer; Gregory J McHugo; Lisa A Marsch; Jürgen Unützer; Stephen J Bartels Journal: J Nerv Ment Dis Date: 2017-08 Impact factor: 2.254
Authors: Gregory E Simon; David Arterburn; Paul Rohde; Evette J Ludman; Jennifer A Linde; Belinda H Operskalski; Robert W Jeffery Journal: J Gen Intern Med Date: 2011-06-28 Impact factor: 5.128
Authors: Gregory E Simon; Paul Rohde; Evette J Ludman; Robert W Jeffery; Jennifer A Linde; Belinda H Operskalski; David Arterburn Journal: Gen Hosp Psychiatry Date: 2010-10-27 Impact factor: 3.238
Authors: Lisa G Rosas; Kristen M J Azar; Nan Lv; Lan Xiao; Jeremy D Goldhaber-Fiebert; Mark B Snowden; Elizabeth M Venditti; Megan M Lewis; Andrea N Goldstein-Piekarski; Jun Ma Journal: Am J Prev Med Date: 2020-02-14 Impact factor: 5.043
Authors: Karen E Stewart; Deborah L Haller; Carol Sargeant; James L Levenson; Puneet Puri; Arun J Sanyal Journal: Liver Int Date: 2014-03-10 Impact factor: 5.828
Authors: Molly E Waring; Kristin L Schneider; Bradley M Appelhans; Andrew M Busch; Matthew C Whited; Stephanie Rodrigues; Stephenie C Lemon; Sherry L Pagoto Journal: J Psychosom Res Date: 2014-03-25 Impact factor: 3.006